ANDA 211980, held by Sun Pharm. Norepinephrine Bitartrate.
As of Nov 15, 2026, ANDA 211980 (Norepinephrine Bitartrate), held by Sun Pharm, was first approved by FDA on Jan 29, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 29, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Norepinephrine BitartrateEQ 1MG BASE/ML ยท injectable;injection | Norepinephrine Bitartrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
